You are here

glimepiride

Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride

Pharmaceutical Business Review

Fri, 02/15/19 - 10:13 am

Boehringer Ingelheim

type 2 diabetes

clinical trials

Bristol-Myers Presents Data

Yahoo/Zacks

Sat, 12/10/11 - 12:56 pm

Bristol-Myers Squibb

Two-Year Data Comparing Cardiovascular Events with Linagliptin and the Sulfonylurea, Glimepiride, Presented as Late-Breaking Poster at ADA

Yahoo/PR NewsWire

Sat, 06/25/11 - 08:42 pm

Boehringer Ingelheim